The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis

BACKGROUND: Major depressive disorder causes a great burden on patients and societies. Venlafaxine and mirtazapine are commonly prescribed as second-line treatment for patients with major depressive disorder worldwide. Previous systematic reviews have concluded that venlafaxine and mirtazapine reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Caroline Kamp, Juul, Sophie, Siddiqui, Faiza, Horowitz, Mark Abie, Moncrieff, Joanna, Munkholm, Klaus, Hengartner, Michael Pascal, Kirsch, Irving, Gluud, Christian, Jakobsen, Janus Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061867/
https://www.ncbi.nlm.nih.gov/pubmed/36991504
http://dx.doi.org/10.1186/s13643-023-02221-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061867/
https://www.ncbi.nlm.nih.gov/pubmed/36991504
http://dx.doi.org/10.1186/s13643-023-02221-5

Ejemplares similares